A new multi-company collaborative announced the launch of a new framework aimed at bolstering research and development of COVID-19 treatments.
Medable spearheaded the effort to develop the ACCESS initiative, according to a press release, in partnership with BioIntelliSense, Datavant, Parexel, PWNHealth and the American Heart Association’s Center for Health Technology and Innovation.
“ACCESS will enable us all to accelerate diagnostic testing and clinical trials—and advance important monitoring and immunity research—so that we can conquer COVID-19 with effective prevention and intervention strategies,” Medable CEO and Co-Founder Michelle Longmire said in a statement. “By empowering people in their homes with ACCESS, we can accelerate research by reducing time for enrollment and data collection.”
To read the full press release, click here.
